Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A

Human Molecular Genetics

Volumn 20, Issue 12, 2011, Pages 2333-2343

  Kumar, Ajay ^a   Yamauchi, Jenny ^a   Girgenrath, Tanya ^a   Girgenrath, Mahasweta ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOD PROTEIN; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEIN KINASE B; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GENE; LAMA2 GENE; LIFESPAN; MOUSE; MUSCLE DEVELOPMENT; MUSCLE MASS; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOFIBROSIS; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; TRANSGENIC MOUSE; WELLBEING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INSULIN-LIKE GROWTH FACTOR I; LAMININ; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOD PROTEIN; MYOGENIN;

MUS;

EID: 79957521292     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr126     Document Type: Article

References (61)

1. Muntoni, F. and Voit, T. (2004) The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul. Disord., 14, 635-649.
2. Muntoni, F., Bertini, E., Bonnemann, C., Brockington, M., Brown, S., Bushby, K., Fiszman, M., Korner, C., Mercuri, E., Merlini, L. et al. (2002) 98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), 7th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE. 26-28th October, 2001, Naarden, The Netherlands. Neuromuscul. Disord., 12, 889-896.
3. Colognato, H. and Yurchenco, P.D. (2000) Form and function: the laminin family of heterotrimers. Dev. Dyn., 218, 213-234.
4. Langenbach, K.J. and Rando, T.A. (2002) Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve, 26, 644-653.
5. Laprise, P., Poirier, E.M., Vezina, A., Rivard, N. and Vachon, P.H. (2002) Merosin-integrin promotion of skeletal myofiber cell survival: differentiation state-distinct involvement of p60Fyn tyrosine kinase and p38alpha stress-activated MAP kinase. J. Cell Physiol., 191, 69-81.
6. Miyagoe, Y., Hanaoka, K., Nonaka, I., Hayasaka, M., Nabeshima, Y., Arahata, K. and Takeda, S. (1997) Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett., 415, 33-39.
7. Girgenrath, M., Beermann, M.L., Vishnudas, V.K., Homma, S. and Miller, J.B. (2009) Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann. Neurol., 65, 47-56.
8. Bentzinger, C.F., Barzaghi, P., Lin, S. and Ruegg, M.A. (2005) Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB J., 19, 934-942.
9. Meinen, S., Barzaghi, P., Lin, S., Lochmuller, H. and Ruegg, M.A. (2007) Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. J. Cell Biol., 176, 979-993.
10. Moll, J., Barzaghi, P., Lin, S., Bezakova, G., Lochmuller, H., Engvall, E., Muller, U. and Ruegg, M.A. (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature, 413, 302-307.
11. Eusebio, A., Oliveri, F., Barzaghi, P. and Ruegg, M.A. (2003) Expression of mouse agrin in normal, denervated and dystrophic muscle. Neuromuscul. Disord., 13, 408-415.
12. Erb, M., Meinen, S., Barzaghi, P., Sumanovski, L.T., Courdier-Fruh, I., Ruegg, M.A. and Meier, T. (2009) Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency. J. Pharmacol. Exp. Ther., 331, 787-795.
13. Kuang, W., Xu, H., Vilquin, J.T. and Engvall, E. (1999) Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency. Lab. Invest., 79, 1601-1613.
14. Hayashi, Y.K., Tezak, Z., Momoi, T., Nonaka, I., Garcia, C.A., Hoffman, E.P. and Arahata, K. (2001) Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy. Neuromuscul. Disord., 11, 350-359.
15. Vachon, P.H., Loechel, F., Xu, H., Wewer, U.M. and Engvall, E. (1996) Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival. J. Cell Biol., 134, 1483-1497.
16. Arahata, K. and Engel, A.G. (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann. Neurol., 16, 193-208.
17. Spencer, M.J. and Tidball, J.G. (2001) Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul. Disord., 11, 556-564.
18. Dominov, J.A., Kravetz, A.J., Ardelt, M., Kostek, C.A., Beermann, M.L. and Miller, J.B. (2005) Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice. Hum. Mol. Genet., 14, 1029-1040.
19. Girgenrath, M., Dominov, J.A., Kostek, C.A. and Miller, J.B. (2004) Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J. Clin. Invest., 114, 1635-1639.
20. Gawlik, K., Miyagoe-Suzuki, Y., Ekblom, P., Takeda, S. and Durbeej, M. (2004) Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice. Hum. Mol. Genet., 13, 1775-1784.
21. Gawlik, K.I., Akerlund, M., Carmignac, V., Elamaa, H. and Durbeej, M. (2010) Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency. PLoS One, 5, e11549.
22. Gawlik, K.I. and Durbeej, M. (2010) Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan. Muscle Nerve, 42, 30-37.
23. Gawlik, K.I., Li, J.Y., Petersen, A. and Durbeej, M. (2006) Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy. Hum. Mol. Genet., 15, 2690-2700.
24. Gawlik, K.I., Mayer, U., Blomberg, K., Sonnenberg, A., Ekblom, P. and Durbeej, M. (2006) Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan. FEBS Lett., 580, 1759-1765.
25. Itagaki, Y., Saida, K. and Iwamura, K. (1995) Regenerative capacity of mdx mouse muscles after repeated applications of myo-necrotic bupivacaine. Acta Neuropathol., 89, 380-384.
26. McGeachie, J.K., Grounds, M.D., Partridge, T.A. and Morgan, J.E. (1993) Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J. Neurol. Sci., 119, 169-179.
27. Girgenrath, M., Kostek, C.A. and Miller, J.B. (2005) Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations. BMC Neurol., 5, 7.
28. Engert, J.C., Berglund, E.B. and Rosenthal, N. (1996) Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol., 135, 431-440.
29. Florini, J.R., Ewton, D.Z. and Coolican, S.A. (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev., 17, 481-517.
30. Adams, G.R. and McCue, S.A. (1998) Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J. Appl. Physiol., 84, 1716-1722.
31. Musaro, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E.R., Sweeney, H.L. and Rosenthal, N. (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet., 27, 195-200.
32. Barton, E.R., Morris, L., Musaro, A., Rosenthal, N. and Sweeney, H.L. (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J. Cell Biol., 157, 137-148.
33. Shavlakadze, T., White, J., Hoh, J.F., Rosenthal, N. and Grounds, M.D. (2004) Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice. Mol. Ther., 10, 829-843.
34. Bittner, R.E., Anderson, L.V., Burkhardt, E., Bashir, R., Vafiadaki, E., Ivanova, S., Raffelsberger, T., Maerk, I., Hoger, H., Jung, M. et al. (1999) Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat. Genet., 23, 141-142.
35. Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. and Magyar, J.P. (2004) Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord., 14, 675-682.
36. Connolly, A.M., Keeling, R.M., Mehta, S., Pestronk, A. and Sanes, J.R. (2001) Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Neuromuscul. Disord., 11, 703-712.
37. Rommel, C., Bodine, S.C., Clarke, B.A., Rossman, R., Nunez, L., Stitt, T.N., Yancopoulos, G.D. and Glass, D.J. (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol., 3, 1009-1013.
38. Grey, A., Chen, Q., Xu, X., Callon, K. and Cornish, J. (2003) Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology, 144, 4886-4893.
39. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J.C., Glass, D.J. et al. (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol., 3, 1014-1019.
40. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H. and Goldberg, A.L. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117, 399-412.
41. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E., Dharmarajan, K. et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science, 294, 1704-1708.
42. Philpot, J., Bagnall, A., King, C., Dubowitz, V. and Muntoni, F. (1999) Feeding problems in merosin deficient congenital muscular dystrophy. Arch. Dis. Child., 80, 542-547.
43. Goldspink, G. (2007) Loss of muscle strength during aging studied at the gene level. Rejuvenation Res., 10, 397-405.
44. Dobrowolny, G., Giacinti, C., Pelosi, L., Nicoletti, C., Winn, N., Barberi, L., Molinaro, M., Rosenthal, N. and Musaro, A. (2005) Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol., 168, 193-199.
45. Gehrig, S.M., Ryall, J.G., Schertzer, J.D. and Lynch, G.S. (2008) Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage. Exp. Physiol., 93, 1190-1198.
46. Lynch, G.S., Cuffe, S.A., Plant, D.R. and Gregorevic, P. (2001) IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul. Disord., 11, 260-268.
47. Palazzolo, I., Stack, C., Kong, L., Musaro, A., Adachi, H., Katsuno, M., Sobue, G., Taylor, J.P., Sumner, C.J., Fischbeck, K.H. et al. (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron, 63, 316-328.
48. Bark, T.H., McNurlan, M.A., Lang, C.H. and Garlick, P.J. (1998) Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am. J. Physiol., 275, E118-E123.
49. Barton-Davis, E.R., Shoturma, D.I. and Sweeney, H.L. (1999) Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol. Scand., 167, 301-305.
50. LeRoith, D. and Roberts, C.T. Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett., 195, 127-137.
51. Rantanen, J., Hurme, T., Lukka, R., Heino, J. and Kalimo, H. (1995) Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab. Invest., 72, 341-347.
52. Taniguchi, M., Kurahashi, H., Noguchi, S., Sese, J., Okinaga, T., Tsukahara, T., Guicheney, P., Ozono, K., Nishino, I., Morishita, S. et al. (2006) Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease? Biochem. Biophys. Res. Commun., 342, 489-502.
53. Noguchi, S., Tsukahara, T., Fujita, M., Kurokawa, R., Tachikawa, M., Toda, T., Tsujimoto, A., Arahata, K. and Nishino, I. (2003) cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum. Mol. Genet., 12, 595-600.
54. Machida, S. and Booth, F.W. (2004) Insulin-like growth factor 1 and muscle growth: implication for satellite cell proliferation. Proc. Nutr. Soc., 63, 337-340.
55. Coolican, S.A., Samuel, D.S., Ewton, D.Z., McWade, F.J. and Florini, J.R. (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem., 272, 6653-6662.
56. Jones, N.C., Fedorov, Y.V., Rosenthal, R.S. and Olwin, B.B. (2001) ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J. Cell Physiol., 186, 104-115.
57. Tamir, Y. and Bengal, E. (2000) Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation. J. Biol. Chem., 275, 34424-34432.
58. Chakravarthy, M.V., Abraha, T.W., Schwartz, R.J., Fiorotto, M.L. and Booth, F.W. (2000) Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway. J. Biol. Chem., 275, 35942-35952.
59. Machida, S., Spangenburg, E.E. and Booth, F.W. (2003) Forkhead transcription factor FoxO1 transduces insulin-like growth factor's signal to p27Kip1 in primary skeletal muscle satellite cells. J. Cell Physiol., 196, 523-531.
60. Xiong, Y., Zhou, Y. and Jarrett, H.W. (2009) Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase/Akt signaling in skeletal muscle in a laminin-dependent manner. J. Cell Physiol., 219, 402-414.
61. Borner, C. (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol., 39, 615-647.